AssetMark Inc’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212 Buy
+13
New +$224 ﹤0.01% 3599
2024
Q3
– Sell
-450
Closed -$13.1K – 2313
2024
Q2
$13.1K Sell
450
-240
-35% -$7.12K ﹤0.01% 1450
2024
Q1
$24.5K Hold
690
– – ﹤0.01% 1261
2023
Q4
$30K Hold
690
– – ﹤0.01% 1236
2023
Q3
$26.4K Hold
690
– – ﹤0.01% 1212
2023
Q2
$28.4K Sell
690
-11
-2% -$529 ﹤0.01% 1172
2023
Q1
$40.2K Buy
701
+11
+2% +$620 ﹤0.01% 1081
2022
Q4
$38.7K Hold
690
– – ﹤0.01% 1097
2022
Q3
$29K Hold
690
– – ﹤0.01% 1062
2022
Q2
$37K Sell
690
-150
-18% -$9.01K ﹤0.01% 996
2022
Q1
$54K Sell
840
-5
-0.6% -$329 ﹤0.01% 901
2021
Q4
$57K Hold
845
– – ﹤0.01% 885
2021
Q3
$58K Hold
845
– – ﹤0.01% 760
2021
Q2
$58K Hold
845
– – ﹤0.01% 732
2021
Q1
$58K Buy
845
+95
+13% +$6.44K ﹤0.01% 710
2020
Q4
$49K Hold
750
– – ﹤0.01% 717
2020
Q3
$35K Hold
750
– – ﹤0.01% 737
2020
Q2
$35K Sell
750
-125
-14% -$6.14K ﹤0.01% 711
2020
Q1
$39K Buy
+875
New +$45.9K ﹤0.01% 732
2018
Q1
– Sell
-20
Closed -$1K – 1672
2017
Q4
$1K Sell
20
-4,312
-100% -$211K ﹤0.01% 1623
2017
Q3
$219K Sell
4,332
-9,648
-69% -$496K ﹤0.01% 462
2017
Q2
$762K Sell
13,980
-50,242
-78% -$2.4M 0.01% 306
2017
Q1
$2.71M Buy
64,222
+52,226
+435% +$2.23M 0.04% 224
2016
Q4
$514K Buy
11,996
+10,000
+501% +$406K 0.01% 317
2016
Q3
$82K Buy
+1,996
New +$83.6K ﹤0.01% 526

Other funds holding IART

AssetMark Inc's IART Position: Q3 2026 in Review

AssetMark Inc opened a new position in Integra LifeSciences (IART) in Q3 2026: 13 shares worth $212. The stake represents ﹤0.01% of the portfolio and ranks #3599 among its holdings. This is a return to the name: AssetMark Inc previously reported a position in IART as recently as Q2 2024.

AssetMark Inc first reported a position in IART in Q3 2016 and has held it in 25 quarters since. The position peaked at $2.71M in Q1 2017. 62 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • AssetMark Inc held 13 shares of Integra LifeSciences worth $212 as of Q3 2026.
  • Integra LifeSciences was a new AssetMark Inc position in Q3 2026.
  • Integra LifeSciences made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3599 holding.
  • AssetMark Inc first reported a position in Integra LifeSciences in Q3 2016 and has held it in 25 quarters since.
  • AssetMark Inc's Integra LifeSciences position peaked at $2.71M in Q1 2017.
  • 62 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.